US2011217412A1PendingUtilityA1

Cholesterol lowering supplement and low cholesterol egg produced by using the same

Assignee: JINIS BIOPHARMACEUTICALS COPriority: Jul 30, 2004Filed: May 16, 2011Published: Sep 8, 2011
Est. expiryJul 30, 2024(expired)· nominal 20-yr term from priority
A23D 9/013A23L 15/00A23K 50/75
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides compositions and methods for producing low cholesterol poultry eggs using hypocholesterolemic compounds, cholesterol lowering supplements, and feeds therefrom. The compositions include industrial by-products obtained during production of pravastatin as effective ingredients for lowering the cholesterol content in eggs. The present invention enables the production of eggs with greatly reduced cholesterol content in an economical way. Therefore, the present invention can be considered the first technique suitable for practical use in the production of low cholesterol eggs using statins.

Claims

exact text as granted — not AI-modified
1 . A composition for producing low cholesterol poultry eggs comprising industrial by-products obtained during production of pravastatin as effective ingredients, wherein the pravastatin production involves bioconversion of compactin to pravastatin using microorganisms. 
     
     
         2 . The composition of  claim 1 , wherein the industrial by-products are obtained during production of pravastatin using microorganisms, separation of the pravastatin and/or purification of the pravastatin. 
     
     
         3 . The composition of  claim 1 , wherein the industrial by-products include at least one of compactin, pravastatin and derivatives thereof. 
     
     
         4 . A feed supplement for producing low cholesterol eggs comprising the composition of  claim 1 . 
     
     
         5 . A feed for producing low cholesterol eggs comprising the composition of  claim 1 . 
     
     
         6 . A method for producing low cholesterol eggs comprising administrating to poultry industrial by-products obtained during production of pravastatin as effective ingredients, wherein the pravastatin production involves bioconversion of compactin to pravastatin using microorganisms. 
     
     
         7 . The method of  claim 6 , wherein the industrial by-products are obtained during production of pravastatin using microorganisms, separation of the pravastatin and/or purification of the pravastatin. 
     
     
         8 . The method of  claim 6 , wherein the industrial by-products include at least one of compactin, pravastatin and derivatives thereof. 
     
     
         9 . The method of  claim 6 , wherein the industrial by-products are added in an amount of 0.01 to 10% by weight to a feed and then the feed is administered at least once daily for at least 5 days. 
     
     
         10 . A low cholesterol egg produced by the method of  claim 6 .

Join the waitlist — get patent alerts

Track US2011217412A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.